IgG Fc Receptors
The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Abstract
Since the description of the first mouse knockout for an IgG Fc receptor seven years ago, considerable progress has been made in defining the in vivo functions of these receptors in diverse biological systems. The role of activating FcγRs in providing a critical link between ligands and effector cells in type II and type III inflammation is now well established and has led to a fundamental revision of the significance of these receptors in initiating cellular responses in host defense, in determining the efficacy of therapeutic antibodies, and in pathological autoimmune conditions. Considerable progress has been made in the last two years on the in vivo regulation of these responses, through the appreciation of the importance of balancing activation responses with inhibitory signaling. The inhibitory FcR functions in the maintenance of peripheral tolerance, in regulating the threshold of activation responses, and ultimately in terminating IgG mediated effector stimulation. The consequences of deleting the inhibitory arm of this system are thus manifested in both the afferent and efferent immune responses. The hyperresponsive state that results leads to greatly magnified effector responses by cytotoxic antibodies and immune complexes and can culminate in autoimmunity and autoimmune disease when modified by environmental or genetic factors. FcγRs offer a paradigm for the biological significance of balancing activation and inhibitory signaling in the expanding family of activation/inhibitory receptor pairs found in the immune system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dendritic cells and the control of immunity
Banchereau, J., & Steinman, R. M. (1998) · Nature · doi:10.1038/32588 · Cited by 14,336
Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets
Clynes, R. A., Towers, T. L., Presta, L. G., & Ravetch, J. V. (2000) · Nature Medicine · doi:10.1038/74704 · Cited by 2,768
Signal transduction by lymphocyte antigen receptors
Weiss, A., & Littman, D. R. (1994) · Cell · doi:10.1016/0092-8674(94)90334-4 · Cited by 2,089
Lanier, L. L. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.359 · Cited by 1,648
Ravetch, J. V., & Kinet, J. P. (1991) · Annual Review of Immunology · doi:10.1146/annurev.iy.09.040191.002325 · Cited by 1,229
Self-citationDaëron, M. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.203 · Cited by 1,227
FcR γ chain deletion results in pleiotrophic effector cell defects
Takai, T., Li, M., Sylvestre, D., Clynes, R., & Ravetch, J. V. (1994) · Cell · doi:10.1016/0092-8674(94)90115-5 · Cited by 951
Self-citationREGULATION OF IMMUNE RESPONSES THROUGH INHIBITORY RECEPTORS
Long, E. O. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.875 · Cited by 939
Regnault, A., Lankar, D., Lacabanne, V., Rodriguez, A., Théry, C., Rescigno, M., Saito, T., Verbeek, S., Bonnerot, C., Ricciardi-Castagnoli, P., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.2.371 · Cited by 898
Augmented humoral and anaphylactic responses in FcγRII-deficient mice
Takai, T., Ono, M., Hikida, M., Ohmori, H., & Ravetch, J. V. (1996) · Nature · doi:10.1038/379346a0 · Cited by 826
Self-citationOno, M., Bolland, S., Tempst, P., & Ravetch, J. V. (1996) · Nature · doi:10.1038/383263a0 · Cited by 781
Self-citationSpontaneous Autoimmune Disease in FcγRIIB-Deficient Mice Results from Strain-Specific Epistasis
Bolland, S., & Ravetch, J. V. (2000) · Immunity · doi:10.1016/s1074-7613(00)00027-3 · Cited by 752
Self-citationThe 3.2-Å crystal structure of the human IgG1 Fc fragment–FcγRIII complex
Sondermann, P., Huber, R., Oosthuizen, V., & Jacob, U. (2000) · Nature · doi:10.1038/35018508 · Cited by 719
Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications
van de Winkel, J. G. J., & Capel, P. J. A. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90166-i · Cited by 692
Uncoupling of Immune Complex Formation and Kidney Damage in Autoimmune Glomerulonephritis
Clynes, R., Dumitru, C., & Ravetch, J. V. (1998) · Science · doi:10.1126/science.279.5353.1052 · Cited by 625
Self-citationFerguson, K. M., Lemmon, M. A., Schlessinger, J., & Sigler, P. B. (1995) · Cell · doi:10.1016/0092-8674(95)90219-8 · Cited by 603
A 13-amino-acid motif in the cytoplasmic domain of FcγRIIB modulates B-cell receptor signalling
Muta, T., Kurosaki, T., Misulovin, Z., Sanchez, M., Nussenzweig, M. C., & Ravetch, J. V. (1994) · Nature · doi:10.1038/368070a0 · Cited by 580
Self-citationActivation of phospholipase Cgamma by PI 3-kinase-induced PH domain-mediated membrane targeting
Falasca, M. (1998) · The EMBO Journal · doi:10.1093/emboj/17.2.414 · Cited by 564
Salim, K., Bottomley, M. J., Querfurth, E., Zvelebil, M. J., Gout, I., Scaife, R., Margolis, R. L., Gigg, R., Smith, C. I., Driscoll, P. C., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01014.x · Cited by 558
Crowley, M. T., Costello, P. S., Fitzer-Attas, C. J., Turner, M., Meng, F., Lowell, C., Tybulewicz, V. L. J., & DeFranco, A. L. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.7.1027 · Cited by 506
Molecular Basis of Fc Receptor Function
Hulett, M. D., & Hogarth, P. M. (1994) · Advances in Immunology · doi:10.1016/s0065-2776(08)60671-9 · Cited by 505
Deletion of SHIP or SHP-1 Reveals Two Distinct Pathways for Inhibitory Signaling
Ono, M., Okada, H., Bolland, S., Yanagi, S., Kurosaki, T., & Ravetch, J. V. (1997) · Cell · doi:10.1016/s0092-8674(00)80337-2 · Cited by 499
Self-citationPROPERTIES OF ANTIBODIES CYTOPHILIC FOR MACROPHAGES
Berken, A., & Benacerraf, B. (1966) · The Journal of Experimental Medicine · doi:10.1084/jem.123.1.119 · Cited by 482
Phospholipase Cγ2 Is Essential in the Functions of B Cell and Several Fc Receptors
Wang, D., Feng, J., Wen, R., Marine, J.-C., Sangster, M. Y., Parganas, E., Hoffmeyer, A., Jackson, C. W., Cleveland, J. L., Murray, P. J., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)00005-4 · Cited by 475
Cytoplasmic Domain Heterogeneity and Functions of IgG Fc Receptors in B Lymphocytes
Amigorena, S., Bonnerot, C., Drake, J. R., Choquet, D., Hunziker, W., Guillet, J.-G., Webster, P., Sautes, C., Mellman, I., & Fridman, W. H. (1992) · Science · doi:10.1126/science.1535455 · Cited by 455
Daëron, M., Latour, S., Malbec, O., Espinosa, E., Pina, P., Pasmans, S., & Fridman, W. H. (1995) · Immunity · doi:10.1016/1074-7613(95)90134-5 · Cited by 451
Impaired IgG-Dependent Anaphylaxis and Arthus Reaction in FcγRIII (CD16) Deficient Mice
Hazenbos, W. L. W., Gessner, J. E., Hofhuis, F. M. A., Kuipers, H., Meyer, D., Heijnen, I. A. F. M., Schmidt, R. E., Sandor, M., Capel, P. J. A., Daëron, M., et al. (1996) · Immunity · doi:10.1016/s1074-7613(00)80494-x · Cited by 443
GENETIC ANALYSIS OF B CELL ANTIGEN RECEPTOR SIGNALING
Kurosaki, T. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.555 · Cited by 432
Scharenberg, A. M., El-Hillal, O., Fruman, D. A., Beitz, L. O., Li, Z., Lin, S., Gout, I., Cantley, L. C., Rawlings, D. J., & Kinet, J.-P. (1998) · The EMBO Journal · doi:10.1093/emboj/17.7.1961 · Cited by 429
Dombrowicz, D., Flamand, V., Brigman, K. K., Koller, B. H., & Kinet, J.-P. (1993) · Cell · doi:10.1016/0092-8674(93)90540-7 · Cited by 399
Clynes, R., Maizes, J. S., Guinamard, R., Ono, M., Takai, T., & Ravetch, J. V. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.1.179 · Cited by 387
Self-citationSHIP Modulates Immune Receptor Responses by Regulating Membrane Association of Btk
Bolland, S., Pearse, R. N., Kurosaki, T., & Ravetch, J. V. (1998) · Immunity · doi:10.1016/s1074-7613(00)80555-5 · Cited by 384
Self-citationMiyajima, I., Dombrowicz, D., Martin, T. R., Ravetch, J. V., Kinet, J. P., & Galli, S. J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119255 · Cited by 372
Self-citationDIVERGENT ROLES FOR F c RECEPTORS AND COMPLEMENT IN VIVO
Ravetch, J. V., & Clynes, R. A. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.421 · Cited by 366
Self-citationRegulation of Antibody Responses via Antibodies, Complement, and Fc Receptors
Heyman, B. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.709 · Cited by 353
Immunoreceptor tyrosine-based inhibition motifs
Vivier, E., & Daëron, M. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)80025-4 · Cited by 351
Liu, Q., Sasaki, T., Kozieradzki, I., Wakeham, A., Itie, A., Dumont, D. J., & Penninger, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.7.786 · Cited by 341
Structural Heterogeneity and Functional Domains of Murine Immunoglobulin G Fc Receptors
Ravetch, J. V., Luster, A. D., Weinshank, R., Kochan, J., Pavlovec, A., Portnoy, D. A., Hulmes, J., Pan, Y.-C. E., & Unkeless, J. C. (1986) · Science · doi:10.1126/science.2946078 · Cited by 333
Self-citationJefferis, R., Lund, J., & Pound, J. D. (1998) · Immunological Reviews · doi:10.1111/j.1600-065x.1998.tb01188.x · Cited by 329
Deletion of Fcγ Receptor IIB Renders H-2b Mice Susceptible to Collagen-induced Arthritis
Yuasa, T., Kubo, S., Yoshino, T., Ujike, A., Matsumura, K., Ono, M., Ravetch, J. V., & Takai, T. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.1.187 · Cited by 325
Self-citationFc Receptors Initiate the Arthus Reaction: Redefining the Inflammatory Cascade
Sylvestre, D. L., & Ravetch, J. V. (1994) · Science · doi:10.1126/science.8066448 · Cited by 321
Self-citationFc receptors are required in passive and active immunity to melanoma
Clynes, R., Takechi, Y., Moroi, Y., Houghton, A., & Ravetch, J. V. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.2.652 · Cited by 321
Self-citationBrooks, D. G., Qiu, W. Q., Luster, A. D., & Ravetch, J. V. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.4.1369 · Cited by 297
Self-citationResistance of Fc receptor- deficient mice to fatal glomerulonephritis.
Park, S. Y., Ueda, S., Ohno, H., Hamano, Y., Tanaka, M., Shiratori, T., Yamazaki, T., Arase, H., Arase, N., Karasawa, A., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3256 · Cited by 263
Phagocytosis mediated by three distinct Fc gamma receptor classes on human leukocytes.
Anderson, C. L., Shen, L., Eicher, D. M., Wewers, M. D., & Gill, J. K. (1990) · The Journal of experimental medicine · doi:10.1084/jem.171.4.1333 · Cited by 262
Induction and Suppression of Collagen-Induced Arthritis Is Dependent on Distinct Fcγ Receptors
Kleinau, S., Martinsson, P., & Heyman, B. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.9.1611 · Cited by 255
Cytotoxic antibodies trigger inflammation through Fc receptors
Clynes, R., & Ravetch, J. V. (1995) · Immunity · doi:10.1016/1074-7613(95)90155-8 · Cited by 250
Self-citationThe RasGAP-Binding Protein p62dok Is a Mediator of Inhibitory FcγRIIB Signals in B Cells
Tamir, I., Stolpa, J. C., Helgason, C. D., Nakamura, K., Bruhns, P., Daeron, M., & Cambier, J. C. (2000) · Immunity · doi:10.1016/s1074-7613(00)80187-9 · Cited by 241
Inhibitory Pathways Triggered by ITIM-Containing Receptors
Bolland, S., & Ravetch, J. V. (1999) · Advances in Immunology · doi:10.1016/s0065-2776(08)60019-x · Cited by 220
Self-citationSHIP Recruitment Attenuates FcγRIIB-Induced B Cell Apoptosis
Pearse, R. N., Kawabe, T., Bolland, S., Guinamard, R., Kurosaki, T., & Ravetch, J. V. (1999) · Immunity · doi:10.1016/s1074-7613(00)80074-6 · Cited by 219
Self-citationPritchard, N. R., Cutler, A. J., Uribe, S., Chadban, S. J., Morley, B. J., & Smith, K. G. C. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00344-4 · Cited by 210
Nakamura, A., Yuasa, T., Ujike, A., Ono, M., Nukiwa, T., Ravetch, J. V., & Takai, T. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.5.899 · Cited by 208
Self-citationGhazizadeh, S., Bolen, J. B., & Fleit, H. B. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37050-3 · Cited by 202
Immunoglobulin G–mediated Inflammatory Responses Develop Normally in Complement-deficient Mice
Sylvestre, D., Clynes, R., Ma, M., Warren, H., Carroll, M. C., & Ravetch, J. V. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.6.2385 · Cited by 202
Self-citationDombrowicz, D., Flamand, V, Miyajima, I., Ravetch, J. V., Galli, S. J., & Kinet, J. P. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119256 · Cited by 198
Self-citationCrystal structure of the human leukocyte Fc receptor, Fc gammaRIIa.
Hogarth, P. M., Maxwell, K. F., Powell, M. S., Hulett, M. D., Bartoň, P., McKenzie, I. F. C., & Garrett, T. (1999) · Nature Structural Biology · doi:10.1038/8241 · Cited by 195
Fc-dependent inhibition of mouse B cell activation by whole anti-mu antibodies.
Phillips, N. E., & Parker, D. C. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.130.2.602 · Cited by 184
Höpken, U. E., Lu, B., Gerard, N. P., & Gerard, C. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.5.749 · Cited by 183
Ujike, A., Ishikawa, Y., Ono, M., Yuasa, T., Yoshino, T., Fukumoto, M., Ravetch, J. V., & Takai, T. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.10.1573 · Cited by 182
Self-citationYamanashi, Y., Tamura, T., Kanamori, T., Yamane, H., Nariuchi, H., Yamamoto, T., & Baltimore, D. (2000) · Genes & Development · doi:10.1101/gad.14.1.11 · Cited by 181
Malbec, O., Fong, D. C., Turner, M., Tybulewicz, V. L. J., Cambier, J. C., Fridman, W. H., & Daëron, M. (1998) · PubMed · Cited by 175
Inhibitory receptors, ITIM sequences and phosphatases
Unkeless, J. C., & Jin, J. (1997) · Current Opinion in Immunology · doi:10.1016/s0952-7915(97)80079-9 · Cited by 173
A Dominant Role for Mast Cell Fc Receptors in the Arthus Reaction
Sylvestre, D. L., & Ravetch, J. V. (1996) · Immunity · doi:10.1016/s1074-7613(00)80264-2 · Cited by 170
Self-citationA complementary DNA clone for a macrophage-lymphocyte Fc receptor
Lewis, V. A., Koch, T., Plutner, H., & Mellman, I. (1986) · Nature · doi:10.1038/324372a0 · Cited by 166
Polymorphisms in IgG Fc receptor IIB regulatory regions associated with autoimmune susceptibility
Jiang, Y., Hirose, S., Abe, M., Sanokawa-Akakura, R., Ohtsuji, M., Mi, X., Li, N., Xiu, Y., Zhang, D., Shirai, J., et al. (2000) · Immunogenetics · doi:10.1007/s002510050641 · Cited by 166
The Inositol Phosphatase SHIP Inhibits Akt/PKB Activation in B Cells
Aman, M. J., Lamkin, T. D., Okada, H., Kurosaki, T., & Ravichandran, K. S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.51.33922 · Cited by 162
Malbec, O., Fong, D. C., Turner, M., Tybulewicz, V. L. J., Cambier, J. C., Fridman, W. H., & Daëron, M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.4.1647 · Cited by 160
Suzuki, Y., Shirato, I., Okumura, K., Ravetch, J. V., Takai, T., Tomino, Y., & Ra, C. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00108.x · Cited by 159
Self-citationYoung, J. D., Ko, S. S., & Cohn, Z. A. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.17.5430 · Cited by 157
Isolation and expression of cDNA clones encoding a human receptor for IgG (Fc gamma RII).
Stuart, S. G., Trounstine, M. L., Vaux, D. J., Koch, T., Martens, C. L., Mellman, I., & Moore, K. W. (1987) · The Journal of experimental medicine · doi:10.1084/jem.166.6.1668 · Cited by 151
Kubagawa, H., Chen, C.-C., Ho, L. H., Shimada, T., Gartland, L., Mashburn, C., Uehara, T., Ravetch, J. V., & Cooper, M. D. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.2.309 · Cited by 148
Self-citationIsolation of cDNAs for two distinct human Fc receptors by ligand affinity cloning.
Stengelin, S., Stamenkovic, I., & Seed, B. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb02913.x · Cited by 145
Titus, J. A., Pérez, P., Kaubisch, A., Garrido, M. A., & Segal, D. M. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.9.3153 · Cited by 138
Takizawa, F., Adamczewski, M., & Kinet, J. P. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.2.469 · Cited by 138
Murine IgG1 complexes trigger immune effector functions predominantly via Fc gamma RIII (CD16).
Hazenbos, W. L. W., Heijnen, I., Meyer, D., Hofhuis, F. M., de Lavalette, C. R., Schmidt, R. E., Capel, P. J., van de Winkel, J. G. J., Gessner, J. E., van den Berg, T. K., et al. (1998) · PubMed · Cited by 137
Function and regulation of a murine macrophage-specific IgG Fc receptor, Fc gamma R-alpha.
Weinshank, R. L., Luster, A. D., & Ravetch, J. V. (1988) · The Journal of experimental medicine · doi:10.1084/jem.167.6.1909 · Cited by 134
Self-citationInvolvement of p72syk, a protein-tyrosine kinase, in Fc gamma receptor signaling
Agarwal, A., Salem, P., & Robbins, K. C. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82337-7 · Cited by 133
Al, G., Barnes, N. C., Dijstelbloem, H. M., & Hogarth, P. M. (1998) · PubMed · Cited by 130
Molecular cloning of a human immunoglobulin G Fc receptor.
Hibbs, M. L., Bonadonna, L., Scott, B. M., McKenzie, I. F., & Hogarth, P. M. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.7.2240 · Cited by 130
Wernersson, S., Karlsson, M. C. I., Dahlström, J., Mattsson, R., Verbeek, J. S., & Heyman, B. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.2.618 · Cited by 129
Wernersson, S., Karlsson, M., Dahlström, J., Mattsson, R., Verbeek, J. S., & Heyman, B. (1999) · PubMed · Cited by 125
Fc receptor signaling and trafficking: a connection for antigen processing
Amigorena, S., & Bonnerot, C. (1999) · Immunological Reviews · doi:10.1111/j.1600-065x.1999.tb01372.x · Cited by 122
Murine IgG1 Complexes Trigger Immune Effector Functions Predominantly via FcγRIII (CD16)
Hazenbos, W. L. W., Heijnen, I. A. F. M., Meyer, D., Hofhuis, F. M. A., Renardel de Lavalette, C., Schmidt, R. E., Capel, P. J. A., van de Winkel, J. G. J., Gessner, J. E., van den Berg, T. K., et al. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.6.3026 · Cited by 120
Physical and functional association of p56lck with Fc gamma RIIIA (CD16) in natural killer cells.
Salcedo, T. W., Kurosaki, T., Kanakaraj, P., Ravetch, J. V., & PERUSSIA, B. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.177.5.1475 · Cited by 118
Self-citationA Codominant Role of FcγRI/III and C5aR in the Reverse Arthus Reaction
Baumann, U., Köhl, J., Tschernig, T., Schwerter-Strumpf, K., Verbeek, J. S., Schmidt, R. E., & Gessner, J. E. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.1065 · Cited by 116
Gavin, A. L., Barnes, N. C., Dijstelbloem, H. M., & Hogarth, P. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.1.20 · Cited by 103
Strachan, A. J., Woodruff, T. M., Haaima, G., Fairlie, D. P., & Taylor, S. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6560 · Cited by 102
Maeda, A., Kurosaki, M., & Kurosaki, T. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.5.991 · Cited by 97
Yuan, R., Clynes, R., Oh, J. S., Ravetch, J. V., & Scharff, M. D. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.4.641 · Cited by 93
Self-citationHigh Pathogenic Potential of Low-Affinity Autoantibodies in Experimental Autoimmune Hemolytic Anemia
Fossati‐Jimack, L., Reininger, L., Chicheportiche, Y., Clynes, R., Ravetch, J. V., Honjo, T., & Izui, S. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.11.1689 · Cited by 86
Self-citationPERUSSIA, B., Landolfi, M. M. T., Qiu, W. Q., Kuziel, W. A., Tucker, P. W., Trinchieri, G., Bennett, M., Ravetch, J. V., & Kumar, V. (1989) · The Journal of Experimental Medicine · doi:10.1084/jem.170.1.73 · Cited by 74
Self-citationCutting Edge: FcγRII-B1 Regulates the Presentation of B Cell Receptor-Bound Antigens
Minskoff, S. A., Matter, K., & Mellman, I. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.5.2079 · Cited by 68
Bonilla, F. A., Fujita, R. M., Pivniouk, V. I., Chan, A. C., & Geha, R. S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040543597 · Cited by 61
Baiu, D. C., Prechl, J., Tchorbanov, A. I., Molina, H. D., Erdei, A., Sulica, A., Capel, P. J., & Hazenbos, W. L. W. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.6.3125 · Cited by 59
Fc gamma RII-B1 regulates the presentation of B cell receptor-bound antigens.
Minskoff, S. A., Matter, K., & Mellman, I. (1998) · PubMed · Cited by 55
Catherine Cone, J., Lu, Y., Trevillyan, J. M., Bjorndahl, J. M., & Phillips, C. A. (1993) · European Journal of Immunology · doi:10.1002/eji.1830231017 · Cited by 52
The mouse Fc receptor for IgG (Ly-17) : molecular cloning and specificity
Hogarth, P. M., Hibbs, M. L., Bonadonna, L., Scott, B., Witort, E. J., Pietersz, G. A., & McKenzie, I. F. C. (1987) · Immunogenetics · doi:10.1007/bf00365906 · Cited by 46
Tec family protein-tyrosine kinases and pleckstrin homology domains in mast cells
Kawakami, Y., Yao, L., Han, W., & Kawakami, T. (1996) · Immunology Letters · doi:10.1016/s0165-2478(96)02659-4 · Cited by 17
Cited by
Alternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
Lanier, L. L. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115526 · Cited by 2,769
Victora, G. D., & Nussenzweig, M. C. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-075032 · Cited by 1,878
Shields, R. L., Lai, J., Keck, R., O'Connell, L. Y., Hong, K., Meng, Y. G., Weikert, S. H. A., & Presta, L. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202069200 · Cited by 1,835
Collaborative Induction of Inflammatory Responses by Dectin-1 and Toll-like Receptor 2
Gantner, B. N., Simmons, R. M., Canavera, S. J., Akira, S., & Underhill, D. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021787 · Cited by 1,643
Metadata
- Authors
- Ravetch, J. V., & Bolland, S.
- Venue
- Annual Review of Immunology
- Publisher
- Annual Reviews
- Published
- 2001-04
- Volume
- 19
- Issue
- 1
- Pages
- 275-290
- ISSN
- 0732-0582 (ISSN-L)
- 1545-3278
- OpenAlex
- W1903287340
- Cited by
- 1,657
- References
- 98
- FWCI
- 10.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.